Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT01310465
Other study ID # FudanU-0457034
Secondary ID
Status Recruiting
Phase Phase 4
First received March 7, 2011
Last updated March 7, 2011
Start date January 2011
Est. completion date April 2012

Study information

Verified date January 2011
Source Fudan University
Contact Chao Li, bachelor
Phone 15202183944
Email lichao0457034@gmail.com
Is FDA regulated No
Health authority China: Food and Drug Administration
Study type Interventional

Clinical Trial Summary

Many patients who have lumbar degenerative disease suffer from osteoporosis or reduced bone mass or low bone mineral density. Among patients with lumbar degenerative disease, some need fusion surgery. But conditions of osteoporosis or low bone mineral density slow down the rate of bone fusion, reduce the success of bone fusion, and ultimately affect the overall effectiveness of surgery. Zoledronic acid is an effective anti-osteoporotic. Many researchers dispute if zoledronic acid can promote the healing of long bone fractures. But few researchers focus on the effect of zoledronic acid to lumbar fusion. In this study, we select patients with lumbar degenerative disease who have had lumbar interbody fusion surgery. Three days postoperatively, the patients were randomized to either one infusion of zoledronic acid or sodium chloride intravenously. We follow all these patients for 6 months. During this time, we detect bone metabolism and bone fusion of these patients. At last, we can tell if zoledronic acid can modify bone metabolism and promote bone fusion.


Recruitment information / eligibility

Status Recruiting
Enrollment 50
Est. completion date April 2012
Est. primary completion date December 2011
Accepts healthy volunteers No
Gender Both
Age group 50 Years to 70 Years
Eligibility Inclusion Criteria:

- Patients with lumbar degenerative disease who have had lumbar interbody fusion surgery

- Age 50-70 years old

- Willing to sign informed consent

Exclusion Criteria:

- Application of strontium ranelate, sodium fluoride or parathyroid hormone

- Application of bisphosphonates more than 8 weeks during 2 years preoperatively

- Suffering from bone fracture during 3 months preoperatively

- Urinary creatinine clearance rate less than 35mL/min

- Serum calcium concentrations greater than 2.75mmol/L or less than 2.00mmol/L

- Pregnancy or breast-feeding women

- Suffering from cancer or other diseases that may be expected to live less than a year

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Intervention

Drug:
zoledronic acid
zoledronic acid, 5mg(100ml), intravenous, one time at three days postoperatively
sodium chloride
sodium chloride, 100ml, intravenous, one time at three days postoperatively

Locations

Country Name City State
China Zhongshan hospital of Fudan university Shanghai Shanghai

Sponsors (1)

Lead Sponsor Collaborator
Fudan University

Country where clinical trial is conducted

China, 

References & Publications (1)

Colón-Emeric C, Nordsletten L, Olson S, Major N, Boonen S, Haentjens P, Mesenbrink P, Magaziner J, Adachi J, Lyles KW, Hyldstrup L, Bucci-Rechtweg C, Recknor C; HORIZON Recurrent Fracture Trial. Association between timing of zoledronic acid infusion and hip fracture healing. Osteoporos Int. 2011 Aug;22(8):2329-36. doi: 10.1007/s00198-010-1473-1. Epub 2010 Dec 9. — View Citation

See also
  Status Clinical Trial Phase
Completed NCT02561182 - Bone Health in Patients With Overgrowth
Completed NCT05736640 - Osseointegrated Transdermal Femoral Amputation Prostheses N/A
Terminated NCT01460147 - Osteoporosis and MRI Study in Hemophilia N/A
Active, not recruiting NCT01798030 - Vitamin D Retrospective Study and Role With Disease
Recruiting NCT05091086 - The Optimal Long Term Treatment Strategy of Anti-resorptive Medications---The Extension of Denosumab Sequential Therapy Phase 4
Completed NCT06274203 - High Dose Vitamin D Supplementation in Children With Sickle Cell Disease N/A
Recruiting NCT02355340 - Bone Mineral Density Status in Pediatric and Adolescent Survivors of Childhood Cancer With History of Bone Fracture
Completed NCT01010230 - Vibration Intervention For Bone Enhancement In Childhood Cancer Survivors N/A
Completed NCT03316625 - Reference Curve on Bone Mineral Density in Young Adult: French Multicenter Study N/A
Not yet recruiting NCT02369289 - Bone Mineral Density in Israeli Female Vegans and Omnivores N/A
Completed NCT00924560 - A Multicenter Study to Evaluate the Effects of a 91-day Oral Contraceptive on Bone Mineral Density in Adolescent Females Phase 2
Completed NCT03400982 - Reference Curve on Bone Mineral Density in Men N/A
Recruiting NCT04900506 - Surgical Approach in Hemiarthroplasty. A Randomized Clinical Trial Comparing Posterior and Anterior Approach N/A
Completed NCT02491008 - Novel Biomarkers and Skeletal Outcomes Associated With Subclinical Thyroid Dysfunction Phase 4
Completed NCT00619047 - The Role of Impact Activity in Peripubertal Bone Accrual N/A
Completed NCT04962854 - Changes of Bone Mineral Density in Total Hip Arthroplasty
Not yet recruiting NCT03437239 - BFR After Bicep Tenodesis N/A
Completed NCT03753100 - Periprosthetic Bone Remodeling in Femoral Neck Fracture Patients; a 5-year Follow up Study N/A
Withdrawn NCT04761666 - Influence of Verticalization on Bone Mineral Density and Biological Parameters of Bone Remodeling in Children With Severe Cerebral Palsy
Enrolling by invitation NCT03835793 - Health After eaRly Menopause Due to Oophorectomy

External Links